<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-2125</journal-id>
<journal-title><![CDATA[Revista Cubana de Medicina General Integral]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Med Gen Integr]]></abbrev-journal-title>
<issn>0864-2125</issn>
<publisher>
<publisher-name><![CDATA[ECIMED]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-21252008000400015</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Bibliomed sobre la diabetes mellitus y la reducción de su mortalidad]]></article-title>
<article-title xml:lang="en"><![CDATA[Bibliomed on diabetes mellitus and the reduction oh its mortality]]></article-title>
</title-group>
<aff id="A">
<institution><![CDATA[,  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2008</year>
</pub-date>
<volume>24</volume>
<numero>4</numero>
<fpage>0</fpage>
<lpage>0</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-21252008000400015&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-21252008000400015&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-21252008000400015&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><body><![CDATA[  <font face="Verdana" size="2"> </font>     <P>      <P>      <P>      <P>     <p align="right"><font face="Verdana" size="2"><B>INFORMACIONES </B></font></p>     <p><B></B></p> <B>      <P>      <P>      <P><font face="Verdana" size="4">Bibliomed sobre la diabetes mellitus y la reducci&oacute;n    de su mortalidad</font>     ]]></body>
<body><![CDATA[<P>&nbsp; </B>      <p>      <p><font size="3"><b><font face="Verdana">Bibliomed on diabetes mellitus and the    reduction oh its mortality</font></b></font>      <p>&nbsp;     <p><B></B> <B>     <P>      <P>      <P><font face="Verdana" size="2">DIABETES MELLITUS/diagn&oacute;stico</font> </B>      <P>      <P><font face="Verdana" size="2">Angus VC, Waugh N. Hospital admission patterns    subsequent to diagnosis of type 1 diabetes in children: a systematic review.    BMC Health Serv Res [serie en internet] 2007 [citado 28 de abril 2008] 7:[Aprox.    1 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2233617&blobtype=pdf">http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2233617&amp;blobtype=pdf</a></FONT></U>    </font>     ]]></body>
<body><![CDATA[<P> </p> <font face="Verdana" size="2">Bays HE, Bazata DD, Clark NG, Gavin JR, Green AJ,  Lewis SJ, et al. Prevalence of self-reported diagnosis of diabetes mellitus and  associated risk factors in a national survey in the US population: SHIELD (Study  to Help Improve Early Evaluation and Management of Risk Factors Leading to Diabetes).  BMC Public Health [serie en internet] 2007 [citado 28 de abril 2008]; 7:[Aprox.  9 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2222165&blobtype=pdf">http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2222165&amp;blobtype=pdf</a></FONT></U>  </font>      <P>      <P><font face="Verdana" size="2">Bour-Jordan H, Bluestone JA. B cell depletion:    a novel therapy for autoimmune diabetes? J Clin Invest [serie en internet] 2007    [citado 8 de abril 2008];117(12):[Aprox. 4 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2096437&blobtype=pd">http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2096437&amp;blobtype=pdf    </a></FONT></U> </font>      <P>      <P><font face="Verdana" size="2">Clarke WL, Anderson S, Farhy L, Breton M, Gonder-Frederick    L, Cox D, et al. Evaluating the clinical accuracy of two continuous glucose    sensors using continuous glucose-error grid analysis. Diabetes Care [serie en    internet] 2005 [citado 28 de abril 2008]; 28(10): [Aprox. 6 p.]. Disponible    en: <U><FONT  COLOR="#0000ff"><a href="http://care.diabetesjournals.org/cgi/content/full/28/10/2412">http://care.diabetesjournals.org/cgi/content/full/28/10/2412</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Faeh D, William J, Yerly P, Paccaud F, Bovet    P. Diabetes and pre-diabetes are associated with cardiovascular risk factors    and carotid/femoral intima-media thickness independently of markers of insulin    resistance and adiposity. Cardiovasc Diabetol [serie en internet] 2007 [citado    8 de abril 2008];6:[Aprox. 10 p.]. Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2148037&blobtype=pdf%20">http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2148037&amp;blobtype=pdf</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Davis TM, Cull CA, Holman RR. A clinical screening    tool identi-fies autoimmune diabetes in adults: response to Diabetes Care [serie    en internet] 2006 [citado 8 de abril 2008]; 29(11):[Aprox.1 p.] Disponible en:    <U><FONT  COLOR="#0000ff"><a href="http://care.diabetesjournals.org/cgi/content/full/29/11/2560%20">http://    care.diabetesjournals.org/cgi/content/full/29/11/2560</a></FONT></U> </font>     <P>      ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">Ferguson SC, Blane A, Wardlaw J, Frier BM, Perros    P, McCrimmon RJ, et al. Influence of an early-onset age of type 1 diabetes on    cerebral structure and cognitive function. Diabetes Care [serie en internet]    2005 [citado 8 de abril 2008];28(6):[Aprox. 7 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://care.diabetesjournals.org/cgi/content/full/28/6/1431">http://care.diabetesjournals.org/cgi/content/full/28/6/1431</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Fourlanos S, Perry C, Stein MS, Stankovich J,    Harrison LC, Colman PG. A clinical screening tool identifies autoimmune diabetes    in adults. Diabetes Care [serie en internet] 2005 [citado 8 de abril 2008];29(5):[Aprox.    7 p.] Disponible en: <U><FONT COLOR="#0000ff"><a href="http://care.diabetesjournals.org/cgi/reprint/28/6/1431">http://care.diabetesjournals.org/cgi/reprint/28/6/1431</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Greiver M. Improving diabetes care in my practice.    Can Fam Physician [serie en internet] 2007 [citado 28 de abril 2008];53(11):[Aprox.    1 p.] Disponible en:<a href="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2231482&blobtype=pdf">    <U><FONT  COLOR="#0000ff">http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2231482&amp;blobtype=pdf</FONT></U>    </a></font>     <P>      <P><font face="Verdana" size="2">Keymeulen B, Gillard P, Mathieu C, Movahedi B,    Maleux G, Delvaux G, et al. Correlation between beta cell mass and glycemic    control in type 1 diabetic recipients of islet cell graft. Proc Natl Acad Sci    USA [serie en internet] 2006 [citado 8 de abril 2008]; 103(46):[Aprox. 6 p.].    Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1859948&blobtype=pdf">http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1859948&amp;blobtype=pdf</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2"> Kim WY, Astrup AS, Stuber M, Tarnow L, Falk    E, Botnar RM, et al. Subclinical coronary and aortic atherosclerosis detected    by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy.    Circulation [serie en internet] 2007 [citado 8 de abril 2008]16;115(2):[Aprox.    9 p.] Disponible en: <U><font face="Verdana" size="2"><u><font  color="#0000ff"><a href="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1859948&blobtype=pdf">http://</a></font></u></font><FONT COLOR="#0000ff"><a href="http://circ.ahajournals.org/cgi/content/full/115/2/228">www.circ.ahajournals.org/cgi/content/abstract/115/2/228    </a></FONT></U> </font>      <P>      ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">Najafian B, Crosson JT, Kim Y, Mauer M. Glomerulotubular    junction abnormalities are associated with proteinuria in type 1 diabetes. J    Am Soc Nephrol [serie en internet] 2006 [citado 8 de abril 2008];17(4 Suppl    2): [Aprox. 8 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://jasn.asnjournals.org/cgi/content/full/17/4_suppl_2/S53">http://jasn.asnjournals.org/cgi/content/full/17/4_suppl_2/S53</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Nelson JL, Gillespie KM, Lambert NC, Stevens    AM, Loubiere LS, Rutledge JC, et al. Maternal microchimerism in peripheral blood    in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc Natl    Acad Sci USA [serie en internet] 2007 [citado 8 de abril 2008];104(5): [Aprox.    6 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17244711">http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=17244711</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Otero Morales J, Su&aacute;rez conejero AM, C&eacute;spedes    Lantigua L. Diabetes mellitus: diagn&oacute;stico positivo. Rev Cubana Med Gen    Integr [serie en internet] 2006 [citado 8 de abril 2008]; 22(1):[Aprox. 7 p.]    Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://scielo.sld.cu/pdf/mgi/v22n1/mgi12106.pdf">http://scielo.sld.cu/pdf/mgi/v22n1/mgi12106.pdf</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Redondo MJ, Babu S, Zeidler A, Orban T, Yu L,    Greenbaum C, et al. Specific human leukocyte antigen DQ influence on expression    of antiislet autoantibodies and progression to type 1 diabetes. J Clin Endocrinol    Metab [serie en internet] 2006 [citado 8 de abril 2008];91(5):[Aprox. 9 p.]    Disponible en: <U><FONT COLOR="#0000ff"><a href="http://jcem.endojournals.org/cgi/content/full/91/5/1705">http://jcem.endojournals.org/cgi/content/full/91/5/1705</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Shih HC, Chou P, Liu CM, Tung TH. Estimation    of progression of multi-state chronic disease using the Markov model and prevalence    pool concept. BMC Med Inform Decis Mak [serie en internet] 2007 [citado 28 de    abril 2008];7:[Aprox. 2 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2241590&blobtype=pdf">http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2241590&amp;blobtype=pdf</a></FONT></U>    </font>     <P>      ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">Slingerland AS. Monogenic diabetes in children    and young adults: challenges for researcher, clinician and patient. Rev Endocr    Metab Disord [serie en internet] 2006 [citado 8 de abril 2008];7(3): [Aprox.    15 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1894829&blobtype=pdf">http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1894829&amp;blobtype=pdf</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Waugh N. Hospital admission patterns subsequent    to diagnosis of type 1 Diabetes in children: a systematic review. BMC Health    Serv Res [serie en internet] 2007 [citado 8 de abril 2008];7:[Aprox. 11 p.]    Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=18053255">http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=18053255</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Zeck W, Panzitt T, Schlembach D, Lang U, McIntyre    D. Management of diabetes in pregnancy: comparison of guidelines with current    practice at Austrian and Australian obstetric center. Croat Med J [serie en    internet] 2007 [citado 28 de abril 2008];48(6):[Aprox. 11 p.]. Disponible en:    <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2213803&blobtype=pdf">http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2213803&amp;blobtype=pdf</a></FONT></U></font>     <P>&nbsp;     <P><font face="Verdana" size="2"><B>FACTORES DE RIESGO</B> </font>      <P>      <P><font face="Verdana" size="2">Booth GL, Kapral MK, Fung K, Tu JV. Recent trends    in cardiovascular complications among men and women with and without diabetes.    Diabetes Care [serie en internet] 2006 [citado 28 de abril2008];29(1): [Aprox.    6 p.]. Disponible en:<a href="http://care.diabetesjournals.org/cgi/content/full/29/1/32">    <U><FONT COLOR="#0000ff">http://care.diabetesjournals.org/cgi/content/full/29/1/32</FONT></U></a>    </font>     <P>      ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">Daly CA, Fox KM, Remme WJ, Bertrand ME, Ferrari    R, Simoons ML, et al. The effect of perindopril on cardiovas-cular morbidity    and mortality in patients with diabetes in the EUROPA study: results from the    PERSUADE substudy. Eur Heart J [serie en internet] 2005 [citado 28 de abril    2008]; 26(14):[Aprox. 10 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://eurheartj.oxfordjournals.org/cgi/reprint/26/14/1369">http://eurheartj.oxfordjournals.org/cgi/reprint/26    /14/1369</a></FONT></U> </font>     <P>      <P><font face="Verdana" size="2">Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term    prognostic value of resting heart rate in patients with suspected or proven    coronary artery disease. Eur Heart J [serie en internet] 2005 [citado 28 de    abril 2008]; 26(10):[Aprox. 8 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://eurheartj.oxfordjournals.org/cgi/reprint/26/10/967">http://eurheartj.oxfordjournals.org    /cgi/reprint/26/10/967</a></FONT></U> </font>     <P>      <P><font face="Verdana" size="2">Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris    KE, Jern S, et al. Impact of diabetes mellitus on regression of electrocardiographic    left ventricular hypertrophy and the prediction of outcome during antihypertensive    therapy: the Losartan Intervention for Endpoint (LIFE) Reduction in Hypertension    Study. Circulation [serie en internet] 2006 [citado 28 de abril 2008]; 113(12):[Aprox.    10 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://circ.ahajournals.org/cgi/content/full/113/12/1588">http://circ.ahajournals.org/cgi/con    tent/full/113/12/1588</a></FONT></U> </font>     <P>&nbsp;     <P><font face="Verdana" size="2"><B>DIABETES MELLITUS/mortalidad</B> </font>      <P>      <P><font face="Verdana" size="2">Bayard V, Chamorro F, Motta J, Hollenberg NK.    Does flavanol intake influence mortality from nitric oxide-dependent processes?    Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama. Int    J Med Sci [serie en internet] 2007 [citado 28 de abril 2008];4(1):[Aprox. 6    p.] Disponible en:<a href="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1796954&blobtype=pdf">    <U><FONT  COLOR="#0000ff">http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1796954&amp;blobtype=pdf</FONT></U>    </a> </font>     <P>      ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">Eurich DT, Majumdar SR, McAlister FA, Tsuyuki    RT, Johnson JA. Improved clinical outcomes associated with metformin in patients    with diabetes and heart failure. Diabetes Care [serie en internet] 2005 [citado    28 de abril 2008];28(10):[Aprox. 7 p.]. Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://care.diabetesjournals.org/cgi/reprint/28/10/2345">http://care.diabetesjournals.org/cgi/reprint/28/10/2345</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Kronmal RA, Barzilay JI, Smith NL, Psaty BM,    Kuller LH, Burke GL, et al. Mortality in pharmacologically treated older adults    with diabetes: the Cardiovascular Health Study, 1989-2001. PLoS Med [serie en    internet] 2006 [citado 28 de abril 2008];3(10): [Aprox. 9 p.] Disponible en:    <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1609124&blobtype=pdf">http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1609124&amp;blobtype=pdf</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Lobelo F, Pate R, Parra D, Duperly J, Pratt M.    Burden of mortality associated to physical inactivity in Bogota, Colombia. Rev    Salud Publica (Bogota) [serie en internet] 2006 [citado 28 de abril 2008];8(Suppl    2):[Aprox. 8 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0124-00642006000500003&lng=en&nrm=iso&tlng=en">http://www.scielosp.org/scielo.php?script=sci_arttext&amp;pid=S0124    -00642006000500003&amp;lng=en&amp;nrm=iso&amp;tlng=en</a></FONT></U> </font>     <P>      <P><font face="Verdana" size="2">Neil HA, DeMicco DA, Luo D, Betteridge DJ, Colhoun    HM, Durrington PN, et al. Analysis of efficacy and safety in patients aged 65-75    years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS). Diabetes    Care [serie en internet] 2006 [citado 28 de abril 2008]; 29(11):[:Aprox. 10    p.]. Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://care.diabetesjournals.org/cgi/content/full/29/11/2378">http://care.diabetesjournals.org/cgi/content/full    /29/11/2378</a></FONT></U> </font>     <P>      <P><font face="Verdana" size="2">Piaggesi A, Macchiarini S, Rizzo L, Palumbo F,    Tedeschi A, Nobili LA, et al. An off-the-shelf instant contact casting device    for the management of diabetic foot ulcers: a randomized prospective trial versus    traditional fiberglass cast. Diabetes Care [serie en internet] 2007 [citado    28 de abril 2008];30(3):[Aprox. 6 p.]. Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://care.diabetesjournals.org/cgi/reprint/30/3/586">http://care.diabetesjournals.org/cgi/reprint/30/3/586</a></FONT></U>    </font>     <P>      ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2">Torp-Pedersen C, Metra M, Charlesworth A, Spark    P, Lukas MA, Poole-Wilson PA, Swedberg K, et al. Effects of metoprolol and carvedilol    on pre-existing and new onset diabetes in patients with chronic heart failure:    data from the Carvedilol or Metoprolol European Trial (COMET). Heart [serie    en internet] 2007 [citado 28 de abril 2008];93(8):[Aprox. 7 p.]. Disponible    en: <U><FONT COLOR="#0000ff"><a href="http://heart.bmj.com/cgi/reprint/93/8/968">http://heart.bmj.com/cgi/reprint/93/8/968</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Triplitt CL. New technologies and therapies in    the management of diabetes. Am J Manag Care [serie en internet] 2007 [citado    28 de abril 2008];13 (Suppl 2):[Aprox. 8 p.]. Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.ajmc.com/files/articlefiles/A169_07apr_Triplitt_S47toS54.pdf">http://www.ajmc.com/files/articlefiles/A169_07apr_Triplitt_S47toS54.pdf</a></FONT></U>    </font>     <P>&nbsp;      <P><font face="Verdana" size="2"><B>DIABETES MELLITUS/prevenci&oacute;n y control</B>    </font>      <P>      <P><font face="Verdana" size="2">Avendano M, Mackenbach JP. Blood glucose levels:    facing a global crisis. Lancet. 2006 Nov 11;368(9548):1631-2.    <br>   </font><font face="Verdana" size="2">Ejemplar localizado en: BMN. </font>      <P>      <P><font face="Verdana" size="2">Herder C, Martin S, Kempf K, Rose B, Kolb H.    Lifestyle and Health Study Group. The DREAM trial. Lancet. 2006 Dec 9;368(9552):2049;    author reply 2050-1.    ]]></body>
<body><![CDATA[<br>   </font><font face="Verdana" size="2">Ejemplar localizado en: BMN. </font>      <P>      <P><font face="Verdana" size="2">M&Ccedil;&Iuml;kinen VP, Soininen P, Forsblom    C, Parkkonen M, Ingman P, Kaski K, et al. 1H NMR metabonomics approach to the    disease continuum of diabetic complications and premature death. Mol Syst Biol.    2008;4:167.    <br>   </font><font face="Verdana" size="2">Ejemplar localizado en: BMN.</font>      <P>&nbsp;     <P><font face="Verdana" size="2"><B>MORTALIDAD/tendencia</B> </font>      <P>      <P><font face="Verdana" size="2">Centers for Disease Control and Prevention (CDC).    Racial disparities in diabetes mortality among persons aged 1-19 years-United    States, 1979-2004. MMWR Morb Mortal Wkly Rep [serie en internet] 2007 [citado    el 1ro. de abril 2007];72(43): [Aprox. 4 p.]. Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.adobe.com/products/acrobat/readstep2.html">http://findarticles.com/p/articles/mi_m0906/is_/ai_n21175027</a></FONT></U>    </font>      <P>      <P><font face="Verdana" size="2">Martinson BC, O'Connor PJ, Pronk NP. Physical    inactivity and short term all cause mortality in adults with chronic disease.    Arch Intern Med [serie en internet] 2001 [citado 28 de abril 2008] 2001 May    14;161(9):[Aprox. 10 p.] Disponible en: <U><FONT COLOR="#0000ff"><a href="http://archinte.ama-assn.org/cgi/reprint/161/9/1173">http://archinte.ama-assn.org/cgi/reprint/161/9/1173</a></FONT></U>    </font>     ]]></body>
<body><![CDATA[<P>      <P><font face="Verdana" size="2">Thomas RJ, Palumbo PJ, Melton LJ 3rd, Roger VL,    Ransom J, O'Brien PC, et al. Trends in the mortality burden asso-ciated with    diabetes mellitus: a population based study in Rochester, Minn, 1970-1994. Arch    Intern Med [serie en internet] 2003 [citado el 1ro. de abril 2007];163(4): [Aprox.    7 p.]. Disponible en: <U><FONT COLOR="#0000ff"><a href="http://archinte.ama-assn.org/cgi/reprint/163/4/445">http://archinte.ama-assn.org/cgi/reprint/163/4/445</a></FONT></U>    </font>      <P>      <P><font face="Verdana" size="2">Wang J, Williams DE, Narayan KM, Geiss LS. Declining    death rates from hyperglycemic crisis among adults with diabetes, U.S., 1985-2002.    Diabetes Care [serie en internet] 2006 [citado el 1ro. de abril 2007];29(9):[Aprox.    5 p.]. Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://care.diabetesjournals.org/cgi/content/full/29/%209/2018">http://care.diabetesjournals.org/cgi/content/full/29    / </a></FONT><a href="http://care.diabetesjournals.org/cgi/content/full/29/9/2018"><FONT  COLOR="#0000ff">9/2018</FONT></a></U> </font>      <P>&nbsp;     <P><font face="Verdana" size="2"><B>DIABETES MELLITUS/etiolog&iacute;a/FACTORES    DE RIESGO</B> </font>      <P>      <P><font face="Verdana" size="2">Brown LC, Johnson JA, Majumdar SR, Tsuyuki RT,    McAlister FA. Evidence of suboptimal management of cardiovascular risk in patients    with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ [serie en    internet] 2004 [citado 28 de abril 2008]; 171(10):[aprox. 4 p.]. Disponible    en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15534311">http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15534311</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Burnet DL, Elliott LD, Quinn MT, Plaut AJ, Schwartz    MA, Chin MH. Preventing diabetes in the clinical setting. J Gen Intern Med [serie    en internet] 2006 [citado 28 de abril 2008]; 21(1):[Aprox. 10 p.] Disponible    en: <U><FONT  COLOR="#0000ff"><a href="http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.0277.x">http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.0277.x</a></FONT></U>    </font>     ]]></body>
<body><![CDATA[<P>      <P><font face="Verdana" size="2">Costa J, Borges M, David C, Vaz Carneiro A. Efficacy    of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis    of randomised controlled trials. BMJ [serie en internet] 2006 [citado 28 de    abril 2008];332 (7550):[Aprox. 7 p.]. Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.bmj.com/cgi/reprint/332/7550/1115">http://www.bmj.com/cgi/reprint/332/7550/1115</a></FONT></U>    </font>      <P>      <P><font face="Verdana" size="2">Fisher M. Diabetes and atherogenesis. Heart.    2004 Mar;90(3):[Aprox. 5 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=14966066">http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=14966066</a></FONT></U>    </font>      <P>      <P><font face="Verdana" size="2">Harris SB, Lank CN. Recommen-dations from the    Canadian Diabetes Association. 2003 guidelines for prevention and management    of diabetes and related cardiovascular risk factors. Can Fam Physician [serie    en internet] 2004 [citado 28 de abril 2008];50:[Aprox. 11 p.] Disponible en:    <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15318682">http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15318682</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Johansen JS, Harris AK, Richly DJ, Ergul A. Oxidative    stress and the use of antioxidants in diabetes: Linking basic science to clinical    practice. Cardiovasc Diabetol [serie en internet] 2005 [citado 28 de abril 2008    2005];Apr 29;4(1):[Aprox. 7 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15862133">http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15862133</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Laatikainen T, Dunbar JA, Chapman A, Kilkkinen    A, Vartliainen E, Heistaro S, Philpot B, et al. Prevention of type 2 diabetes    by lifestyle intervention in an Australian primary health care setting: Greater    Green Triangle (GGT) Diabetes Prevention Project. BMC Public Health [serie en    internet] 2007 [citado 28 de abril 2008];19;7(147):[Aprox. 7 p.]. Disponible    en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17877832">http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=17877832</a></FONT></U>    </font>     ]]></body>
<body><![CDATA[<P>      <P><font face="Verdana" size="2">Myers J, Atwood JE, Froelicher V. Active lifestyle    and diabetes. Circulation. 2003 May 20;107(19):2392-4.    <br>   </font><font face="Verdana" size="2">Ejemplar localizado en: BMN. </font>      <P>      <P><font face="Verdana" size="2">Vargas RB, Mangione CM, Asch S, Keesey J, Rosen    M, Schonlau M, Keeler EB. Can a chronic care model collaborative reduce heart    disease risk in patients with diabetes? J Gen Intern Med [serie en internet]    2007 [citado 28 de abril 2008]; 22(2):[Aprox. 8 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17356989">http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=17356989</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Walker EA, Molitch M, Kramer MK, Kahn S, Ma Y,    Edelstein S, Smith K, Johnson MK, Kitabchi A, Crandall J. Adherence to preventive    medications: predictors and outcomes in the Diabetes Prevention Program. Diabetes    Care [serie en internet] 2006 [citado 28 de abril 2008]; 29(9):[Aprox. 6 p.]    Disponible en: <U><FONT COLOR="#0000ff"><a href="http://care.diabetesjournals.org/cgi/content/full/29/9/1997">http://care.diabetesjournals.org/cgi/content/full/29/9/1997</a></FONT></U>    </font>     <P>      <P><font face="Verdana" size="2">Wu HI. A case study of type 2 diabetes self-management.    Biomed Eng Online [serie en internet] 2005 [citado 28 de abril 2008];4(1):[Aprox.    11 p.] Disponible en: <U><FONT  COLOR="#0000ff"><a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=15644138">http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15644138    </a></FONT></U></font>     <P>&nbsp;     ]]></body>
<body><![CDATA[<P><font face="Verdana" size="2"><B>Descriptores MeSH y DeCS utilizados para localizar    la informaci&oacute;n encontrada: </B></font>     <P><font face="Verdana" size="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MeSH &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DeCS</B></font>    <font size="2"> </font>     <P>      <P><font face="Verdana" size="2">DIABETES MELLITUS/diagnosis &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DIABETES    MELLITUS/diagn&oacute;stico </font>      <P><font face="Verdana" size="2">DIABETES MELLITUS/mortality &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DIABETES    MELLITUS/mortalidad </font>      <P><font face="Verdana" size="2">DIABETES MELLITUS/prevention &amp; control &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DIABETES    MELLITUS/prevenci&oacute;n y control </font>      <P><font face="Verdana" size="2">DIABETES MELLITUS/trends &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DIABETES    MELLITUS/tendencia </font>      <P><font face="Verdana" size="2">DIABETES MELLITUS/etiology &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DIABETES    MELLITUS/etiolog&iacute;a </font>      <P><font face="Verdana" size="2">RISK FACTORS &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;FACTORES    DE RIESGO </font>       ]]></body>
</article>
